|
|
1.
|
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial. MedStar authors:
Year: 2021
Citation: - Nature Medicine. 27(10):1818-1824, 2021 10.
Department: - MedStar Heart and Vascular Institute
Medline publication type:
All authors: - Axelsson A, Bach RG, Becker JR, Benson L, Braunwald , Bundgaard H, Burns KM, Canter C, Cirino AL, Colan SD, Day SM, Ho CY, Lakdawala NK, Lever HM, MacRae CA, Margossian R, McMurray JJV, Mestroni L, Murphy AM, Orav EJ, Owens AT, Patel AR, Pereira AC, Rossano JW, Russell MW, Seidman CE, Solomon SD, Soslow JH, Taylor MRG, Thrush P, VANISH Investigators, Vargas JD, Wheeler MT, Wilmot I, Zahka K
|
|
|
2.
|
Clinical and economic impact of ventricular assist device infections: a real-world claims analysis. MedStar authors:
Year: 2024
Citation: - Journal of Medical Economics. 27(1):62-68, 2024 Jan-Dec.
Department: - MedStar Heart and Vascular Institute, Baltimore
Medline publication type:
All authors: - Peleg AY, Feller ED, Muller M, Schulte-Eistrup S, McGiffin D, Zimpfer D, Holbrook R, Margetta J, Seshadri S, Mokadam NA
|
